The real tragedy on Married At First Sight that Australia should be talking about....
8 March 2017
Australia, we need to talk. This week’s dramatic episodes of Married At First Sight have highlighted a tragedy which is ripping Australian families apart. Yet no one is talking about it.
Whilst public discussion focuses on Cheryl and Andrew’s tumultuous relationship, we should be talking about something far more sinister. At their ‘relationship boot camp’ Cheryl was clearly shown sporting badly sunburnt shoulders and back. Her skin was bright red, it looked painful, and I’m sure viewers noticed. Yet no-one batted an eyelid.
Well, I am calling it. The national discussion about young Australians and melanoma needs to start, and it needs to start now. Our young adults are dying from melanoma. Sons, daughters, brothers, sisters, young parents – lost to melanoma, Australia’s national cancer, at the prime of their lives.
Melanoma is the most common cancer affecting 15-39 year-old Australians. It kills more 20-39 year olds than any other single cancer. One Australian dies from melanoma every six hours. Yet, it is largely preventable.
Intense, intermittent UV exposure leading to sunburn radically increases your chance of developing potentially deadly melanoma. So why are we sitting back and admiring a young woman with a bad case of sunburn on an Australian reality television show, and not discussing it?
Time to get with the program. The famous line, “I love a sunburnt country”, was written way back in 1908. Sun tanning products became sunscreen products back in the 80s, for a reason. Television shows moved on from showing contestants driving without seatbelts, or smoking, to send the right public health and safety messages. It is time to place the same importance on sending life-saving sun safety messages to impressionable young Australians. We banned sunbeds (another driver for melanoma), time to ban sunburn.
Cheryl’s sunburn was front and centre during Melanoma March, our annual awareness month, when I meet a truly heart-wrenching number of partners and parents who have lost their loved ones to melanoma at 24, 32 or 38. Come on Australia, who is ready to join the conversation and help us end melanoma?
CEO, Melanoma Institute Australia
For more information, please contact: Jennifer Durante |Melanoma Institute Australia | 0412 798 990 | firstname.lastname@example.org
"International collaboration remains the key to ensuring this pioneering research continues so we can increase survival rates for advanced melanoma patients and move us closer to achieving our goal of zero deaths from melanoma," says Professor Georgina Long, of the clinical trial results presented at ESMO 2018.
Research that could change clinical practice for high-risk Stage III melanoma patients has been presented at the European Society for Medical Oncology (ESMO) Congress in Munich.
A larger, monthly dose of immunotherapy can give melanoma patients more freedom without sacrificing effectiveness.
The Australasian Melanoma Conference, hosted by the Australasian Melanoma Conference Committee, was held in Melbourne on the weekend, with many of MIA's clinicians in attendance.
The two men who discovered checkpoint inhibitors, the brakes of the immune system, were awarded the Nobel Prize in Physiology or Medicine on Monday, October 1.
The World Health Organisation (WHO) is releasing the 4th edition of Classification of Skin Tumours.
Former Executive Director of Melanoma Institute Australia Professor John Thompson awarded the prestigious 2018 RPA Foundation Research Medal.
Clinicians, patients and other stakeholders in the cancer community are invited to make submissions in support of the PBS listing for pembrolizumab.
The World Congress on Cancers of the Skin 2018 has featured many minds from MIA sharing their expertise and wealth of knowledge with over 1000 attendees from around the world.
Melanoma Institute Australia is delighted to announce the appointment of Matthew Browne as Chief Executive Officer (CEO).
It was a full house this week at Melanoma Institute Australia thanks to our ‘Melanoma in Practice: Nurse Conference’.
A new study from The University of Sydney shows that sunscreen reduces melanoma risk by 40 per cent when used from a young age.
Melanoma Institute Australia (MIA) has launched a free e-learning portal to educate healthcare professionals about the latest advances in melanoma diagnosis and treatment.
When David lost his life last year, he was 33, with three daughters under six.
Clinical trials are just that – trials in a clinical setting to evaluate the effectiveness or otherwise of individual and combination treatments.
Melanoma Institute Australia scooped the award pool at the Annual Scientific Meeting of the International Academy of Pathology.
Melanoma patients across Australia will benefit from the release of updated clinical care guidelines.
An American study has discovered a link between early detection and marital status in melanoma diagnosis.
An international course on melanoma pathology in Paris, France co-directed by Professor Richard Scolyer took place over the weekend.